These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6613605)

  • 1. Monoamine uptake in brain synaptosomes after administration of copper to rats.
    Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):33-8. PubMed ID: 6613605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in dopamine uptake in rat striatal synaptosomes after an acute in vivo administration of organic and inorganic lead.
    Komulainen H; Pietarinen R; Tuomisto J
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):381-9. PubMed ID: 6880773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca-dependence of accumulation of monoamines into synaptosomes and its inhibition by copper.
    Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):193-9. PubMed ID: 6138919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heavy metals on monoamine uptake and release in brain synaptosomes and blood platelets.
    Komulainen H; Tuomisto J
    Neurobehav Toxicol Teratol; 1982; 4(6):647-9. PubMed ID: 7170022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes.
    Tuomisto J; Tuomisto L
    Med Biol; 1980 Feb; 58(1):33-7. PubMed ID: 7382578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant-derived neurotoxic amino acids (beta-N-oxalylamino-L-alanine and beta-N-methylamino-L-alanine): effects on central monoamine neurons.
    Lindström H; Luthman J; Mouton P; Spencer P; Olson L
    J Neurochem; 1990 Sep; 55(3):941-9. PubMed ID: 1974606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparations.
    Rosland JH; Hole K
    J Pharm Pharmacol; 1990 Jun; 42(6):437-8. PubMed ID: 1979627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H; Fonlupt P; Pacheco H
    C R Seances Soc Biol Fil; 1984; 178(1):38-44. PubMed ID: 6331605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlordecone interaction with catecholamine binding and uptake in rat brain synaptosomes.
    Desaiah D
    Neurotoxicology; 1985; 6(1):159-65. PubMed ID: 2581192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations.
    Lai JC; Leung TK; Guest JF; Lim L; Davison AN
    Biochem Pharmacol; 1980 Oct; 29(20):2763-7. PubMed ID: 6776961
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine uptake into synaptosomes from various regions of rat brain following lithium administration and withdrawal.
    Ahluwalia P; Singhal RL
    Neuropharmacology; 1981 May; 20(5):483-7. PubMed ID: 6787450
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels.
    Warenycia MW; Smith KA; Blashko CS; Kombian SB; Reiffenstein RJ
    Arch Toxicol; 1989; 63(2):131-6. PubMed ID: 2730337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug.
    Wong DT; Robertson DW; Bymaster FP; Krushinski JH; Reid LR
    Life Sci; 1988; 43(24):2049-57. PubMed ID: 2850421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of 5-hydroxytryptamine uptake in rabbit hypothalamic synaptosomes but not in blood platelets by zinc and lead ex vivo.
    Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):166-74. PubMed ID: 6624484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally rigid amphetamine analogs as inhibitors of monoamine uptake by brain synaptosomes.
    Tuomisto J; Tuomisto L; Pazdernik TL
    J Med Chem; 1976 May; 19(5):725-7. PubMed ID: 1271416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B; Taylor DA
    Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cu2+ induces Ca2+-dependent neurotransmitter release from brain catecholaminergic nerve terminals.
    Wang JK
    Eur J Pharmacol; 1999 Jun; 373(2-3):163-9. PubMed ID: 10414435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.
    Koe BK
    J Pharmacol Exp Ther; 1976 Dec; 199(3):649-61. PubMed ID: 994022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine.
    Baker SP; Standifer KM; Kalberg CJ; Pitha J; Sumners C
    J Neurochem; 1988 Apr; 50(4):1044-52. PubMed ID: 2894406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.